ストックスクリーナーアプリを入手
8.21
1.32%
-0.11
アフターアワーズ：
8.35
0.14
+1.71%
Xeris Biopharma Holdings Inc (XERS) 最新ニュース
Rice Hall James & Associates LLC Acquires Shares of 251,066 Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Xeris Biopharma Holdings Inc (XERS) Cash Flow - TradingKey
TradingKey - TradingKey
Xeris Biopharma Holdings Inc (XERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Xeris Biopharma Holdings Inc (XERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Xeris Biopharma Holdings, Inc. Revenue Breakdown – NASDAQ:XERS - TradingView
ETFs Investing in Xeris Biopharma Holdings, Inc. Stocks - TradingView
Xeris Biopharma Holdings, Inc. $XERS Shares Sold by Granahan Investment Management LLC - MarketBeat
XERS|Xeris Biopharma Holdings Inc|Price:8.320|Chg%:-0.090 - TradingKey
Xeris Biopharma Holdings Inc (XERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xeris Biopharma Holdings Inc (XERS) Fundamental & Financial Data - Stocktwits
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 - BioSpace
Xeris Biopharma to report Q2 2026 results on Aug 6 - scanx.trade
Press Release: Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 - Moomoo
Xeris Biopharma to report Q2 results, host conference call - Bitget
XERS5927663 Bond Coupon Profile — Rate & Payments - TradingView
XERS5927663 Bond Risk Profile - TradingView
XERS5927663 Bond Profile — Key Metrics - TradingView
Xeris Biopharma Eliminates 2028 Convertible Notes Via Exchanges - TipRanks
Xeris Biopharma (Nasdaq: XERS) ends 8% 2028 notes via cash and stock - Stock Titan
Emerald Mutual Fund Advisers Trust Acquires New Shares in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Enterprise value to revenue forward of Xeris Biopharma Holdings, Inc. – NASDAQ:XERS - TradingView
Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last? - Yahoo Finance
Price to earnings forward of Xeris Biopharma Holdings, Inc. – NASDAQ:XERS - TradingView
Form 144 XERIS BIOPHARMA HOLDINGS For: 7 July By Investing.com - Investing.com Nigeria
Insider Sell: Steven Pieper Sells 45,000 Shares of Xeris Biophar - GuruFocus
Form 4 Xeris Pharmaceuticals Inc For: 7 July By Investing.com - Investing.com Nigeria
Xeris Biopharma CFO Steven Pieper sells $383,176 in company stock - Investing.com
Xeris Biopharma CFO Steven Pieper sells $383,176 in company stock By Investing.com - Investing.com Nigeria
Xeris Biopharma (XERS) officer sells 45,000 shares under Rule 10b5-1 plan - Stock Titan
Steven Pieper sells 17,400 shares for $147,900 — XERS - Stock Titan
Enterprise value to EBITDA forward of Xeris Biopharma Holdings, Inc. – NASDAQ:XERS - TradingView
Insider: 400-share purchase, 17,000 RSUs — XERS - Stock Titan
Xeris Biopharma Holdings Inc. (XERS) Q1 2026 Earnings: Surprise Profitability Drives 3.5% Stock Uptick - dars.gov.et
Why Xeris Biopharma (XERS) Is Up 7.7% After Governance, IP, And Balance Sheet MovesAnd What's Next - Sahm
Xeris Biopharma Holdings, Inc. (XERS) Leads with High RSI of 84 - GuruFocus
Xeris Biopharma (XERS) Surges 3.5% as Biotech Momentum BuildsPrice Action Signals - dars.gov.et
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)July 3, 2026 - BioSpace
Xeris Biopharma Holdings (XERS) Patent Win Puts Its Valuation Back In Focus - Sahm
XERSXeris Biopharma Holdings Inc Options - Finviz
Beth Hecht Sells 16,666 Shares of Xeris Biopharma Holdings Inc (XERS) - GuruFocus
Form 4 Xeris Pharmaceuticals Inc For: 2 July By Investing.com - Investing.com India
Director at Xeris Biopharma (NASDAQ: XERS) receives stock and options grants - Stock Titan
Xeris Biopharma (XERS) director Nerissa Kreher listed as reporting person on Form 3 - Stock Titan
Xeris Biopharma (XERS) officer sells 90,000 shares under 10b5-1 plan - Stock Titan
Planned sale: Xeris Biopharma (XERS) officer trades 16,666 shares - Stock Titan
Insider 10b5-1 sales scheduled at XERS: 16,667 shares on 05/01 and 06/01/2026 - Stock Titan
[144] Xeris Biopharma Holdings, Inc. SEC Filing - Stock Titan
Xeris names CEO John Shannon as Board Chair effective July 1, 2026 - scanx.trade
Xeris Pharmaceuticals appoints new director and board chair - TipRanks
Xeris Biopharma (NASDAQ: XERS) adds Nerissa Kreher and reshapes board - Stock Titan
Xeris CEO picks up chairman role at fast-growing biopharma - Crain's Chicago Business
Xeris Announces Updates to Its Board of Directors - BioSpace
Xeris Biopharma Holdings, Inc. Announces Board Changes, Effective July 1, 2026 - marketscreener.com
Is Xeris Biopharma Holdings, Inc. (XERS) Stock Positioned for Long-Term Growth With Extended Keveyis Exclusivity? - Insider Monkey
Xeris names CEO John Shannon as board chair, adds director By Investing.com - Investing.com Nigeria
Xeris Taps CEO to Additionally Serve as Chairman - Moomoo
Xeris names CEO John Shannon as board chair, adds director - Investing.com
0.30%
2.01%
大文字化:
|
ボリューム (24 時間):